I don't think that anyone can disagree with the notion that, no matter what the area is, medical research is important. In fact, I like hearing about what is occurring outside of the United States because I know that practices can vary. This is especially true when concerning glioblastoma research, which is something that I have had my focus on for quite some time. With bevacizumab being the kind of term not many will recognize, a learning experience as far as this goes is deserved.
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
With bevacizumab being approved for usage in the United States beforehand, keep in mind that restrictions were put in place. The article said that it was only implemented to help recurrent cases, not those which have been newly diagnosed. Of course, there were concerns with this method. The American Society of Clinical Oncology said that this particular drug didn't exactly show a great benefit but I think that there is still potential, if it is being utilized in Japan for the sake of enhancing studies.
Does all of this mean that better findings are to come? I can only hope that this is the case because I support all of the ideas of glioblastoma research and how they can play into the kind of work done. I believe that ideas can develop but not until more facts are brought into the picture. My only hope is that better results are had because of this approved drug and who is to say that better therapies won't rise to the surface sooner than expected?
It's no wonder why this study had focused so much on glioma in the past. For those who don't know, this is seen as the most common growth that is seen within the brain or the spinal cord, difficult to treat by means of surgery. Out of all of the tumors in the world, these make up about 80% of all of them, which goes to show you just how common they are amongst patients. As a result, making sure that treatments are tailored to help them is imperative.
An article that was posted on Medscape reported on glioblastoma research, more specifically the work done thanks to the Japanese Military of Health, Labor, and Welfare and bevacizumab. It seems like malignant cases would be targeted and the usage of chemo, along with radiation, would potentially help patients. You may be interested to know, though, that there have been prior cases as well. This is the kind of news which, in my opinion, is worthy of mention by authorities on the matter, V.A.B.C. included.
With bevacizumab being approved for usage in the United States beforehand, keep in mind that restrictions were put in place. The article said that it was only implemented to help recurrent cases, not those which have been newly diagnosed. Of course, there were concerns with this method. The American Society of Clinical Oncology said that this particular drug didn't exactly show a great benefit but I think that there is still potential, if it is being utilized in Japan for the sake of enhancing studies.
Does all of this mean that better findings are to come? I can only hope that this is the case because I support all of the ideas of glioblastoma research and how they can play into the kind of work done. I believe that ideas can develop but not until more facts are brought into the picture. My only hope is that better results are had because of this approved drug and who is to say that better therapies won't rise to the surface sooner than expected?
About the Author:
Contact Voices Against Brain Cancer if you're looking for more information about glioblastoma.. Free reprint available from: Bevacizumab& How It May Aid Glioblastoma Research.
No comments:
Post a Comment